Atlas Genetics Ltd today announces the appointment of David Whitaker as Operations Director with immediate effect.
David joins Atlas from DNA Electronics, where he worked as Manufacturing & Mechanical Engineering Manager, responsible for the development of a fully portable, point-of-care genetic test device. This project involved a wide range of technical disciplines including microfluidics, electronics and molecular biology. He worked closely with the acting Chief Scientific Officer on the overall management of the project and held direct responsibility for all device engineering activities.
Prior to this, he spent five years as a Principal Consultant in PA Consulting’s Technology and Innovation Practice. During his tenure, he successfully developed and patented a range of medical devices for both big pharma and start-up companies. Before joining PA Consulting, David worked in a variety of medical device engineering, contract engineering and consulting positions at companies including Ivax Pharmaceuticals, Futura Medical West Pharmaceuticals and Risdon Pharma.
David has First Class BEng degree in Mechanical & Manufacturing Engineering with Management from the University of Leeds.
Dr John Clarkson, Chief Executive Officer of Atlas, commented: “At Atlas, we have worked hard over the past year to enhance and develop our senior management team. David brings considerable operational expertise which will be important as we enter a new phase of product manufacture and growth, further progressing Atlas towards becoming a first class diagnostics company.”
With healthcare costs under increasing downward pressure, providers are constantly striving to improve efficiency and access to care whilst reducing the number of unnecessary hospital visits. As shown by others, this can be aided by moving patient testing away from central laboratories and in to Point-of-Care (PoC) settings. To meet these demands, Atlas has developed the io® system, a unique PoC diagnostic platform for the ultra-rapid, inexpensive and accurate diagnosis of infectious diseases, based on a highly sensitive electrochemical detection technology.